BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 21105782)

  • 1. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
    Dey AK; Srivastava IK
    Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvants and delivery systems for viral vaccines--mechanisms and potential.
    Jennings R; Simms JR; Heath AW
    Dev Biol Stand; 1998; 92():19-28. PubMed ID: 9554256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
    Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Starch microparticles as vaccine adjuvant.
    Rydell N; Stertman L; Sjöholm I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):807-28. PubMed ID: 16296780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-based systems for the delivery of vaccine antigens.
    Arca HC; Günbeyaz M; Senel S
    Expert Rev Vaccines; 2009 Jul; 8(7):937-53. PubMed ID: 19538118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology of vaccine adjuvants.
    Ribeiro CM; Schijns VE
    Methods Mol Biol; 2010; 626():1-14. PubMed ID: 20099117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature.
    Mrsny RJ
    J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and direction of immune responses by vaccine adjuvants.
    Schijns VE
    Crit Rev Immunol; 2001; 21(1-3):75-85. PubMed ID: 11642615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination adjuvants: the next generation of adjuvants?
    Mutwiri G; Gerdts V; van Drunen Littel-van den Hurk S; Auray G; Eng N; Garlapati S; Babiuk LA; Potter A
    Expert Rev Vaccines; 2011 Jan; 10(1):95-107. PubMed ID: 21162624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioadhesive delivery systems for mucosal vaccine delivery.
    Baudner BC; O'Hagan DT
    J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity in response to particulate antigen-delivery systems.
    Storni T; Kündig TM; Senti G; Johansen P
    Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving vaccine performance with adjuvants.
    Vogel FR
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S266-70. PubMed ID: 10875797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of vaccine design-Lessons from nature.
    Zepp F
    Vaccine; 2010 Aug; 28 Suppl 3():C14-24. PubMed ID: 20713252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR; Letvin NL
    Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
    de Veer M; Meeusen E
    Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.